Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children withcraniopharyngiomas

Chinese Medical Journal

Volumn 121, Issue 20, 2008, Pages 2077-2082

  Li, Gui Mei ^a   Sun, Xiao Jun ^a   Shao, Peng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Children; Craniopharyngiomas; Hormone replacement therapy; Multiple pituitary hormone deficiency; Postoperative

Indexed keywords

CHORIONIC GONADOTROPIN; CORTICOTROPIN; DESMOPRESSIN; ESTRADIOL; FOLLITROPIN; GROWTH HORMONE; HUMAN MENOPAUSAL GONADOTROPIN; HYDROCORTISONE; HYPOPHYSIS HORMONE; LEVOTHYROXINE; LUTEINIZING HORMONE; PROLACTIN; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN; THYROXINE; VASOPRESSIN; HUMAN GROWTH HORMONE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CRANIOPHARYNGIOMA; DIABETES INSIPIDUS; ENDOCRINE SURGERY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS DISEASE; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROLACTIN BLOOD LEVEL; QUALITY OF LIFE; SCHOOL CHILD; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; WATER DEPRIVATION; BLOOD; HYPOPHYSIS TUMOR; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PATHOPHYSIOLOGY;

ADOLESCENT; CHILD; CRANIOPHARYNGIOMA; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN-LIKE GROWTH FACTOR I; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY HORMONES; PITUITARY NEOPLASMS; THYROTROPIN; THYROXINE;

EID: 58749106080     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200810020-00025     Document Type: Article

References (18)

1. Shi XE, Wu B, Zhou ZQ, Fan T, Zhang YL. Microsurgical treatment of craniopharyngiomas: report of 284 patients. Chin Med J 2006; 119: 1653-1663.
2. Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M. Surgical treatment of craniopharyngioma: experience with 168 patients. J Neurosurg 1999; 99: 237-250.
3. Duff JD, Meyer FB, Ilstrup DM, Laws Jr ER, Schleck CD, Scheithauer BW. Long-term outcome for surgically resected craniopharyngiomas. Neurosurgery 2000; 46: 291-305.
4. Maira G, Anile C, Colosimo C, Cabezas C. Craniophayngiomas of the third ventricle: translamina terminalis approach. Neurosurgery 2000; 47: 857-865.
5. Honegger J, Buchfelder M, Fahlbusch R. Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg 1999; 99: 251-257.
6. Zhang YQ, Wang CC, Ma ZY. Pediatric craniopharyngiomas: clinicomorphological study of 189 cases. Pediatr Neurosurg 2002; 36: 80-84.
7. Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT. Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 2004; 89: 81-86.
8. Bin-Abbas B, Mawlawi H, Sakati N, Khafaja Y, Chaudhary MA, Al-Ashwal A. Endocrine sequelae of childhood craniopharyngioma. J Pediatr Endocrinol Metab 2001; 14: 869-874.
9. Codner E, Mericq V, Ugarte F, Iniguez G, Espinoza M, Avila A, et al.Usefulness of the measurement of insulin-like growth factor (IGF-I) and IGF-1 binding protein-3 (IGFBP-3) for the diagnosis of growth hormone (GH) deficiency in children. Rev Med Chil 1999; 127: 807-813.
10. Juul A, Holm K, Kastrup KW, Pedersen SA, Michaelsen KF, Scheike T, et al. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 1997; 82: 2497-2502.
11. Weinzimer SA, Homan SA, Ferry RJ, Moshang T. Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours. Clin Endocrinol 1999; 51: 339-345.
12. Grumbach MM, Bin-Abbas BS, Kaplan SL. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency. Horm Res 1998; 49 Suppl 2: 41-57.
13. Seminara S, Stagi S,Candura L, Scrivano M, Lenzi L, Nanni L, et al. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth? Horm Metab Res 2005; 37: 751-756.
14. Gibney J, Wolthers T, Johannsson G, Umpleby AM, Ho KK. Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 2005; 289: E266-E271.
15. Baker DL, Kees UR, Price PJ, Willoghby ML. Late leukemic relapse 10 years from diagnosis in a child on recombinant human growth hormone. Pediatr Hematol Oncol 1993; 10: 55-62.
16. Taha DR, Bastian W, Castells S. Growth hormone replacement therapy in children with leukemia in remission. Clin Pediatr 2001; 40: 441-445.
17. Tacke J, Bolder U, Herrmann A, Berger G, Jauch KW. Long-term risk of gastrointestinal tumor recurrence after postoperative treatment with recombinant human growth hormone. J Parenter Enteral Nutr 2000; 24: 140-144.
18. Blethen SL, Allen DB, Graves D, August G, Moshang T, Rosenfeld R. Safety of recombinant deoxyribonucleic acid-derived growth hormone: the national cooperative growth study experience. J Clin Endocrinol Metab 1996; 81: 1704-1710.